BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15677697)

  • 1. Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases.
    Ghittoni R; Patrussi L; Pirozzi K; Pellegrini M; Lazzerini PE; Capecchi PL; Pasini FL; Baldari CT
    FASEB J; 2005 Apr; 19(6):605-7. PubMed ID: 15677697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases.
    Ghittoni R; Napolitani G; Benati D; Ulivieri C; Patrussi L; Laghi Pasini F; Lanzavecchia A; Baldari CT
    Eur J Immunol; 2006 Nov; 36(11):2885-93. PubMed ID: 17048274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
    Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
    Blanco-Colio LM; Muñoz-García B; Martín-Ventura JL; Lorz C; Díaz C; Hernández G; Egido J
    Circulation; 2003 Sep; 108(12):1506-13. PubMed ID: 12952848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases.
    Zhu Y; Casey PJ; Kumar AP; Pervaiz S
    Cell Death Dis; 2013 Apr; 4(4):e568. PubMed ID: 23559002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins reduce amyloid-beta production through inhibition of protein isoprenylation.
    Ostrowski SM; Wilkinson BL; Golde TE; Landreth G
    J Biol Chem; 2007 Sep; 282(37):26832-26844. PubMed ID: 17646164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells.
    Sidaway JE; Davidson RG; McTaggart F; Orton TC; Scott RC; Smith GJ; Brunskill NJ
    J Am Soc Nephrol; 2004 Sep; 15(9):2258-65. PubMed ID: 15339975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
    Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
    Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin-mediated inhibition of prenylation of Rab27b and Rap1a in platelets attenuates their prothrombotic capacity and modulates clot structure.
    Jalal MM; Whyte CS; Coxon FP; Mutch NJ
    Platelets; 2023 Dec; 34(1):2206921. PubMed ID: 37139869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase.
    Schmidmaier R; Baumann P; Simsek M; Dayyani F; Emmerich B; Meinhardt G
    Blood; 2004 Sep; 104(6):1825-32. PubMed ID: 15161667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of protein geranylgeranylation specifically interferes with CD40-dependent B cell activation, resulting in a reduced capacity to induce T cell immunity.
    Shimabukuro-Vornhagen A; Zoghi S; Liebig TM; Wennhold K; Chemitz J; Draube A; Kochanek M; Blaschke F; Pallasch C; Holtick U; Scheid C; Theurich S; Hallek M; von Bergwelt-Baildon MS
    J Immunol; 2014 Nov; 193(10):5294-305. PubMed ID: 25311809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells.
    Cafforio P; Dammacco F; Gernone A; Silvestris F
    Carcinogenesis; 2005 May; 26(5):883-91. PubMed ID: 15705602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
    Lee MH; Cho YS; Han YM
    Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia.
    Bi X; Baudry M; Liu J; Yao Y; Fu L; Brucher F; Lynch G
    J Biol Chem; 2004 Nov; 279(46):48238-45. PubMed ID: 15364922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells.
    Verhulst A; D'Haese PC; De Broe ME
    J Am Soc Nephrol; 2004 Sep; 15(9):2249-57. PubMed ID: 15339974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA.
    Choi M; Rolle S; Rane M; Haller H; Luft FC; Kettritz R
    Kidney Int; 2003 Jan; 63(1):96-106. PubMed ID: 12472772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin interferes with activation of human CD4(+) T cells via inhibition of small guanosine triphosphatase (GTPase) activity and caspase-independent apoptosis.
    Brinkkoetter PT; Gottmann U; Schulte J; van der Woude FJ; Braun C; Yard BA
    Clin Exp Immunol; 2006 Dec; 146(3):524-32. PubMed ID: 17100774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme A reductase without decreasing cholesterol synthesis.
    Blank N; Schiller M; Krienke S; Busse F; Schätz B; Ho AD; Kalden JR; Lorenz HM
    J Immunol; 2007 Sep; 179(6):3613-21. PubMed ID: 17785796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin enhances chemotherapy in cervical cancer via inhibition of multiple prenylation-dependent GTPases-regulated pathways.
    Pan Q; Xu J; Ma L
    Fundam Clin Pharmacol; 2020 Feb; 34(1):32-40. PubMed ID: 31058344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.